SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Chemo Pharma Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
506365 INE320M01019 87.63082 Not Listed 0 17.42 0 0 10
Quarters :
ParticularsJun 2025(Rs.Cr)Mar 2025(Rs.Cr)Dec 2024(Rs.Cr)
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 0.02-0.16-0.15
Total Income0.02-0.16-0.15
Total Expenditure 11.830.020.02
PBIDT-11.80-0.18-0.17
Interest 0.000.000.00
PBDT-11.81-0.18-0.17
Depreciation0.000.000.00
Tax0.000.200.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.00-0.040.00
Reported Profit After Tax-11.81-0.34-0.17
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-11.81-0.34-0.17
    
EPS (Unit Curr.)-78.70-2.26-1.17
EPS (Adj) (Unit Curr.)-78.70-2.26-1.17
Calculated EPS (Unit Curr.)-78.70-2.26-1.17
Calculated EPS (Adj) (Unit Curr.)-78.70-2.26-1.17
Calculated EPS (Ann.) (Unit Curr.)-314.80-9.06-4.66
Calculated EPS (Adj) (Ann.) (Unit Curr.)-314.80-9.06-4.66
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity1.501.501.50
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00